Chikungunya virus (CHIKV): What can be expected after the acute phase?;La enfermedad producida por el virus chikungunya. ¿Qué esperar luego del estadio agudo?

Reumatologia Clinica

Volumn 12, Issue 1, 2016, Pages 1-3

  Khoury, Vianna J ^a   Camilo, Pablo R ^b  

^a Pontificia Universidad Catolica Madre y Maestra   (Dominican Republic)

^b Clinica Corominas   (Dominican Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; CHIKUNGUNYA VIRUS; EDITORIAL; NONHUMAN; CARIBBEAN ISLANDS; CHIKUNGUNYA FEVER; EPIDEMIC; HUMAN; TRANSMISSION;

ACUTE DISEASE; CHIKUNGUNYA FEVER; EPIDEMICS; HUMANS; WEST INDIES;

EID: 84954233088     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2015.12.002     Document Type: Article

References (33)

1. Mason P.J., Haddow A.J. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53; an additional note on Chikungunya virus isolations and serum antibodies. Trans. R. Soc. Trop. Med. Hyg. 1957, 51:238-240.
2. Blackburn N.K., Besselaar T.G., Gibson G. Antigenic relationship between Chikungunya virus strains and O'nyong nyong virus using monoclonal antibodies. Res Virol 1995, 146:69-73.
3. Tesh R.B. Arthritides caused by mosquito-borne virus. Ann Rev Med 1982, 33:31-40.
4. Suranjith L., Seneviratne S.L., Gurugama P., Perera J. International Society of Travel Medicine, 1195-1982. J Travel Med 2007, 14:320-325.
5. Lo Presti A., Lai A., Cella E., Zehender G., Ciccozzi M. Chikungunya virus, epidemiology, clinics and phylogenesis: A review. Asian Pacific Journal of Tropical Medicine 2014, 925-932. journal homepage:www.elsevier.com/locate/apjtm, Disponible en: http://www.ecdc.europa.eu/en/healthtopics/vectors.
6. Chipwaza B., Mugasa J.P., Selemani M., Amuri M., Mosha F., Ngatunga S.D., et al. Dengue and Chikungunya fever among viral diseases in outpatient febrile children in Kilosa district Hospital, Tanzania. PLoS Negl Trop Dis 2014, 8:e3335.
7. Lee V.J., Chow A., Zheng X., Carrasco L.R., Cook A.R., Lye D.C., et al. Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults. PLoS Negl Trop Dis 2012, 6:e1786.
8. Mohd Zim M.A., Sam I.C., Omar S.F., Chan Y.F., AbuBakar S., Kamarulzaman A. Chikungunya infection in Malaysia: Comparison with dengue infection in adults and predictors of persistent arthralgia. J Clin Virol 2013, 56:141-145.
9. Schuffenecker I., Iteman I., Michault A., Murri S., Frangeul L., Vaney M.C., et al. Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak. PloS Med 2006, 3:e263.
10. Moya J., Pimentel R., Puello J. Chikungunya: un reto para los servicios de salud de la República Dominicana. Rev Panam Salud Publica. 2014, 36:331-335.
11. Yazdani R., Kaushik V.V. Chikungunya fever. Rheumatology (Oxford) 2007, 46:1214-1215.
12. Borgherini G., Poubeau P., Staikowsky F., Lory M., le Moullec N., Becquart J.P., et al. Outbreak of chikungunya on Reunion Island: Early clinical and laboratory features in 157 adult patients. Clin Infect Dis 2007, 44:1401-1407.
13. Lakshmi V., Neeraja M., Subbalaxmi M.V., Parida M.M., Dash P.K., Santhosh S.R., et al. Clinical features and molecular diagnosis of Chikungunya fever from South India. Clin Infect Dis 2008, 46:1436-1442.
14. Mahendradas P., Avadhani K., Shetty R. Chikungunya and the eye: A review. J Ophthalmic Inflamm Infect 2013, 3:35.
15. Dupuis-Maguiraga L., Noret M., Brun S., le Grand R., Gras G., Roques P. Chikungunya disease: Infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 2012, 6:e1446.
16. Gasque P., Couderc T., Lecuit M., Roques P., Ng L.F.P. Chikungunya virus pathogenesis and immunity. Vector Borne Zoonotic Dis 2015, 15.
17. Cabié A., Ledrans M., Abel S. Chikungunya Virus Infections. N Engl J Med 2015, 373:93-95.
18. Suranjith L., Seneviratne S.L., Gurugama P., Perera J. International Society of Travel Medicine, 1195-1982. J Travel Med 2007, 14:320-325.
19. Chen W., Foo S-S., Rulli N.E., Taylor A., Sheng K-Ch., Herrero L.J., et al. Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. PNAS 2014, 111. Disponible en: www.pnas.org/cgi/doi/10.1073/pnas.1318859111.
20. Mathew J., Goyal V., George E., Thekkemuriyil D.V., Jayakumar B., Chopra A., et al. Rheumatic-musculoskeletal pain and disorders in a naïve group of individual 15 months following a Chikungunya viral epidemic in south India: A population based observational study. Int J Clin Pract 2011, 65:1306-1312.
21. Simon F., Parola P., Grandadam M., Fourcade S., Oliver M., Brouqui P., et al. Chikungunya infection: An emerging rheumatism among travelers returned from Indian Ocean Islands. Report of 47 cases. Medicine (Baltimore) 2007, 86:123-137.
22. Chopra A., Anuradha V., Lagoo-Joshi V., Kunjir V., Salvi S., Saluja M., et al. Chikungunya virus aches and pains: An emerging challenge. Arthritis Rheum 2008, 58:2921-2930.
23. Manimunda S.P., Vijayachari P., Uppoor R., Sugunan A.P., Singh S.S., Rai S.K., et al. Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 2010, 104:392-399.
24. Leparc-Goffart I., Nougaire'de A., Cassadou S., Prat C., de Lamballerie X. Chikungunya in the Americas. Lancet 2014, 383:514.
25. www.paho.org.
26. Institut de Veille Sanitaire. Situation épidémiologique du chikungunya dans les Antilles. Saint Maurice, France: INVS; 2014 [acceso 18 Ago 2014]. Disponible en: http://www.invs.sante.fr/fr/Publications-et-outils/Pointsepidemiologiques/Tous-les-numeros/Antilles-Guyane/2014/Situation-epidemiologique-du-chikungunya-dans-les-Antilles.
27. Kowalzik S., Xuan N.V., Weissbrich B., Scheiner B., Schied T., Drosten C., et al. Characterisation of a chikungunya virus from a German patient returning from Mauritius and development of a serological test. Med Microbiol Immunol 2008, 197:381-386.
28. Chua C.L., Chan Y.F., Sam I.C. Characterisation of mouse monoclonal antibodies targeting linear epitopes on Chikungunya virus E2 glycoprotein. J Virol Methods 2014, 195:126-133.
29. Chikungunya Fever Fact Sheet-CDC Division of Vector Borne Infectious Diseases.[Online] [acceso 2006]. Disponible en: http://www.cdc.gov/ncidod/chikungunya/chickfact.htm.
30. Horcada M.L., Díaz-Calderón C., Garrido L. Chikungunya fever. Rheumatic manifestations of an emerging disease in Europe. Reumatol Clin 2015, 11:161-164.
31. Patricia Richi Alberti, Martina Steiner, Óscar Illera Martín, Patricia Alcocer Amores, Tatiana Cobo Ibáñez, Santiago Muñoz Fernández. Imported chikungunya fever in Madrid. Reumatol Clin. (in press).
32. Sam I.C., Kümmerer B.M., Chan Y.F., Roques P., Drosten C., AbuBakar S. Updates on chikungunya epidemiology, clinical disease, and diagnostics. Vector Borne Zoonotic Dis 2015, 15:223-230.
33. Pimentel R., Skewes-Ramm, Moya J. Chikungunya en la República Dominicana: lecciones aprendidas en los primeros seis meses. Rev Panam Salud Pública. 2014, 36:336-341.